MIG is a dominant lymphocyte-attractant chemokine in lichen planus lesions

Journal of Investigative Dermatology

Volumn 111, Issue 6, 1998, Pages 1003-1009

  Spandau, Ulrich ^a   Toksoy, Atiye ^a   Goebeler, Matthias ^a   Bröcker, Eva Bettina ^a   Gillitzer, Reinhard ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Chemotaxis; Dermatitis; Inflammation; Interface

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CHEMOATTRACTANT; CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GROWTH RELATED ONCOGENE ALPHA; INTERLEUKIN 8; LYMPHOCYTE ANTIGEN; MACROPHAGE CHEMOTACTIC FACTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOKINE; RANTES; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; LICHEN PLANUS; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MONONUCLEAR CELL; PRIORITY JOURNAL; SKIN INFLAMMATION; T LYMPHOCYTE;

EID: 0032456750     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1998.00426.x     Document Type: Article

References (39)

1. Akasu R, From L, Kahn HJ: Lymphocyte and Macrophage subsets in active and inactive lesions of lichen planus. Am J Dermatopathol 15:217-223, 1993
2. Amichay D, Gazzinelli RT, Karupiah G, Moench TR, Sher A, Farber JM: Genes for chemokines MuMig and Crg-2 are induced in protozoan and viral infections in response to IFN-γ with patterns of tissue expression that suggest nonredundant roles in vivo. J Immunol 157:4511-4520, 1996
3. Barker JNWN, Jones ML, Swenson CL, et al: Monocyte chemotaxis and activating factor production by keratinocytes in response to IFN-γ. J Immunol 146:1192-1197, 1991a
4. Barker JNWN, Mitra RS, Griffiths CEM, Dixit VM, Nickoloff BJ: Keratinocytes as initiators of inflammation. Lancet 337:211-214, 1991b
5. Boyd AS, Neldner KH:. Lubbock. Lichen planus. J Am Acad Dermatol 25:593-619, 1991
6. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA: MCP-1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 91:3652-3656, 1994
7. Devergne O, Marfaing-Koka A, Schall TT, et al: Production of the RANTES chemokine in delayed-type hypersensitivity reactions: Involvment of macrophages and endothelial cells. J Exp Med 179:1689-1694, 1994
8. Engelhardt E, Toksoy A, Goebeler M, Debus S, Broecker EB, Gillitzer R: The chemokines IL8, GROα, MCP-1, IP-10 and MIG are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Path 1998, in press.
9. Gillitzer R, Berger R, Mielke V, Muller C, Wolff K, Stingl G: Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ. J Invest Dermatol 97:73-79, 1991
10. Gillitzer R, Wolff K, Tong D, et al: MCP-1 mRNA Expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol 101:127-131, 1993
11. Gillitzer R, Ritter U, Spandau U, Goebeler M, Bröcker EB: Differential expression of gro-α and IL-8 mRNA in Psoriasis: a model for neutrophil Migration and accumulation in vivo. J Invest Dermatol 107:778-782, 1996
12. Goebeler M, Toksoy A, Spandau U, Engelhardt E, Bröcker EB, Gillitzer R: The CXC chemokine Mig is highly expressed in the papillae of psoriatic lesions. J Pathol 183:89-95, 1998
13. Jinquan T, Frydengerg J, Mukaida N, Bonde J, Larsen CG, Matsushima K, Thestrup-Pedersen K: Recombinant human growth-regulated oncogene-alpha induces T lymphocyte chemotaxis. J Immunol 155:5359-5368, 1995
14. Kulke R, Todt-Pingel I, Rademacher D, Rowert J, Schroder JM, Christophers E: Co-localized overexpression of GRO-alpha and IL-8 mRNA is restricted to the suprapapillary layers of psoriatic lesions. J Invest Dermatol 106:526-530, 1996
15. Larson CG, Andersen AO, Apella E, Oppenheim JJ, Matsushima K: The neutrophil activating protein (NAP-1) is also chemotactic for T-lymphocytes. Science 243:1464-1466, 1989
16. LeBoit P: Interface dermatitis. Arch Dermatol Philadelphia: 129:1324-1328, 1993
17. Lever WF, Schaumburg-Lever G: Histopathology of the Skin. Philadelphia: JB Lippincott, 1996
18. Liao F, Rabin RL, Yanelli JR, Koniaris LG, Vanguri P, Farber JM: Human Mig chemokine: Biochemical and functional characterization. J Exp Med 182:1301-1314, 1995
19. Loetscher M, Gerber B, Loetscher P, et al: Chemokine receptor specific for IP-10 and Mig: structure, function, and expression in activated T lymphocytes. J Exp Med 184:963-969, 1998
20. Ludwig A, Petersen F, Zahn S, Götze O, Schröder JM, Flad HD, Brandt E: The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2. Blood 90:4588-4597, 1997
21. Miller MD, Krangel MS: Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 12:17-46, 1992a
22. Miller MD, Krangel MS: The human cytokine I-309 is a monocyte chemoattractant. Proc Natl Acad Sci USA 89:2950-2954, 1992b
23. Norris DA: Cytokine modulation of adhesion molecules in the regulation of immunologic cytotoxicity of epidermal targets. J Invest Dermatol 95:111S-120S, 1990
24. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K: Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 9:617-648, 1991
25. de Panfilis G, Manara G, Ferrari C, Manfredi G, Allegra F: Imbalance in phenotypic expression of T cell subpopulations during different evolutional stages of lichen planus lesions. Acta Derm Venereol 63:369-375, 1983
26. Premack BA, Schall TJ: Chemokine receptors: gateway to inflammation and infection. Nat Med 2:1174-1178, 1996
27. Ritter U, Moll H, Laskay T, Broecker EB, Velazco O, Becker I, Gillitzer R.: Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J Infect Dis 173:699-709, 1996
28. Schall TJ, Bacon K, Toy KJ, Goeddel DV: Selective attraction of monocytes and T-lymphocytes of the memory phenotype by cytokine RANTES. Nature 347:669-671, 1990
29. Schroeder JM: Cytokine networks in the skin. J Invest Drematol 105:20S-24S, 1995
30. Shiohara T, Nickoloff BJ, Moriya N, Gotoh C, Nagashima M: In vivo effects of interferon-gamma and anti-interferon-gamma antibody on the experimentally induced lichenoid tissue reaction. Br J Dermatol 119:199-206, 1988
31. Strieter RM, Polverini PJ, Arenberg DA, Kunkel SL: The role of CXC chemokines as regulators of angiogenesis. Shock 4:155-160, 1995
32. Taub DD, Conlon KL, Loyd AR, Oppenheim JJ, Kelvin DJ: Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science 260:355-358, 1993
33. Tensen CP, Vermeer MH, van der Stoop PM, van Beek P, Scheper RJ, Boorsma DM, Willemze R: Epidermal interferon-g inducible protein-10 (IP-10) and monokine induced by g-interferon (Mig) but not IL-8 inRNA expression is associated with epidermotropism in cutaneous T cell lymphomas. J Invest Dermatol 111:222-226, 1998
34. Tessier PA, Naccache PH, Clark-Lewis I, Gladue RP, Neote KS, McColl SR: Chemokine networks in vivo. J Immunol 159:3595-3602, 1997
35. Uguccioni M, D'Apuzzo M, Loetscher M, Dewald B, Baggiolini M: Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1α and MIP-1β on human monocytes. Eur J Immunol 25:64-68, 1995
36. Walz A, Burgener R, Car B, Baggiolini M, Kunkel SL, Strieter RM: Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin-8. J Exp Med 174:1355-1362, 1991
37. Yamamoto T, Osaki T: Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus. J Invest Dermatol 104:784-788, 1995
38. Yoshimura T, Yuhki N, Moore SK, Appella E, Lerman MI, Leonard EJ: Human monocyte chemoattractant protein-1 (MCP-1). Fullength cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes and sequence similarity to mouse competence gene JE. FEBS Lett 244:437-193, 1989
39. Yu X, Barnhill RL, Graves DT: Expression of MCP-1 in delayed type hypersensitivity reactions in the skin. Lab Invest 71:226-235, 1994